Mesoblast
MESO
#4329
Rank
S$3.13 B
Marketcap
S$24.31
Share price
3.59%
Change (1 day)
67.35%
Change (1 year)

Mesoblast (MESO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$0.24 Billion

According to Mesoblast 's latest financial reports the company's total liabilities are S$0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mesoblast - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30S$0.25 B12.88%
2023-06-30S$0.22 B-1.27%
2022-06-30S$0.22 B4.5%
2021-06-30S$0.21 B-14.49%
2020-06-30S$0.25 B11.06%
2019-06-30S$0.23 B15.87%
2018-06-30S$0.19 B4.36%
2017-06-30S$0.19 B-8.92%
2016-06-30S$0.20 B-50.34%
2015-06-30S$0.42 B3.52%
2014-06-30S$0.40 B26.99%
2013-06-30S$0.32 B5.06%
2012-06-30S$0.30 B0.83%
2011-06-30S$0.30 B13604.07%
2010-06-30S$2.21 M29.43%
2009-06-30S$1.71 M-20.02%
2008-06-30S$2.14 M99.65%
2007-06-30S$1.07 M-84.97%
2006-06-30S$7.13 M91.25%
2005-06-30S$3.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
S$0.15 B-35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$4.08 M-98.32% Bahamas